Physical Activity for Intellectual Disability, Mild to Moderate

Phase-Based Progress Estimates
University of Kansas Medical Center, Kansas City, KS
Intellectual Disability, Mild to Moderate+1 More
Physical Activity - Behavioral
18 - 65
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to examine the feasibility and initial efficacy of a healthy lifestyles intervention for the prevention of weight gain and the promotion of basic life skills related to improving health in transition age young adults with intellectual disabilities.

Eligible Conditions

  • Intellectual Disability, Mild to Moderate

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 16 Secondary · Reporting Duration: Week 12

Across 12 weeks
Daily Physical Activity
Individual Goals
Work Capacity
Week 12
Body Mass Index
Caregiver Stress
Cooking Skills
Dietary Intake
Lower Body Strength
Physical Function
Upper Body Strength
Waist circumference
Week 12
Week 12
Semi Structure Interview

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Education Arm
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Physical Activity · No Placebo Group · N/A

Education ArmExperimental Group · 2 Interventions: Cooking Skills, Physical Activity · Intervention Types: Behavioral, Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Activity
Completed Phase 3

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: week 12
Closest Location: University of Kansas Medical Center · Kansas City, KS
Photo of university of kansas medical center 1Photo of university of kansas medical center 2Photo of university of kansas medical center 3
2011First Recorded Clinical Trial
1 TrialsResearching Intellectual Disability, Mild to Moderate
755 CompletedClinical Trials

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
390 Previous Clinical Trials
156,575 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to communicate through spoken language.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.